About Us

Our mission is to improve patients' lives by developing transformative immunotherapies for immune-based diseases. We envision Foundery will become the premier biotechnology venture “studio” efficiently validating and translating early drug concepts into groundbreaking medicines by seamlessly working with innovators and industry partners. We are led by our belief that discovery is the basis for the next immunological breakthroughs.

Learn about our science

Founding Principles


Empowering Co-Innovation with Founders

We prize and nurture academic collaborations throughout the discovery and development process. We invest in compelling science of emerging and senior academic scientists by providing infrastructure and expertise to transform discoveries into next-generation immunotherapies. We partner with collaborators by providing research funding and sharing economic returns.


Novel Science

We combine internal immunology expertise with those of academic collaborators and world-class scientists, then utilize artificial intelligence (AI) and deep immune phenotyping datsets (e.g., Immune Archetype Platform) to enhance our understanding of the immune system in health and disease. We conduct experiments to effectively evaluate and advance novel concepts and targets. Our decisions to prioritize validated targets and build Pharma-ready development candidates are data-driven. We share our paradigm-shifting discoveries in top-tier, peer-reviewed journals, and partner with prominent scientific investigators, investors, and biopharmaceutical partners to forge new biotech companies.


Capital Efficiency To Generate Exceptional Returns

Our programs are selected and led by an experienced R&D team that uses an iterative, dual-pronged approach to drug discovery and validation; targets are identified via predictive AI/ML-based methods, then validated and de-risked with confirmatory, highly reproducible experiments to ensure optimal capital deployment to high-value targets. Our extensive biologics development experience, rigorous AI-enabled target vetting and real-time, insights-based decision-making allow us to be capital-efficient. We enable Limited Partners to invest in multiple de-risked development candidates and realize top decile financial returns through biopharmaceutical partnering.



We are committed to a culture of personnel growth and promote teamwork, inclusion, diversity, mentoring, and career development. We strive to create a highly interactive, nurturing, and rewarding work environment for our team members, which cultivates their talents and inspires them to achieve personal and company goals through collaboration.

Contact Us

Interested in learning more? We're looking forward to hearing from you.